How to score the impact of treatment on cutaneous neurofibromas in clinical trials
- PMID: 38084905
- DOI: 10.1093/bjd/ljad492
How to score the impact of treatment on cutaneous neurofibromas in clinical trials
Conflict of interest statement
Conflicts of interest N.O. works with some of the authors of the original paper (L.F., C.B., P.W.) on neurofibromatosis 1 as a pathologist in the same institution (Henri Mondor Hospital) and shares with them research projects within the NFL (‘Neurofibromatosis and Lymphomas oncogenesis’) team.
Comment on
-
A core outcome domain set to assess cutaneous neurofibromas related to neurofibromatosis type 1 in clinical trials.Br J Dermatol. 2024 Jan 23;190(2):216-225. doi: 10.1093/bjd/ljad397. Br J Dermatol. 2024. PMID: 37877514
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical